.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Dr. Rebecca Müller

Vortrag

22.09.2022
13:40 – 13:50 6 Min. 4 Min.
Abstractvortrag
VS-13-2
Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors
10. Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie, 19. COVID-19
22.09.2022
16:40 – 16:45 3 Min. 2 Min.
Poster
PS-1-4
Establishment of a mobile plasma donation bus in Germany
1. Blutspende und Donormanagement, 2. Versorgungsforschung

Weitere Beteiligungen

22.09.2022
13:40 – 13:50 6 Min. 4 Min.
Abstractvortrag
VS-13-2
Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors
10. Hämostaseologie – Koagulopathien, Plasmaderivate und Hämophilie, 19. COVID-19
22.09.2022
13:50 – 14:00 6 Min. 4 Min.
Abstractvortrag
VS-13-3
Long-term Follow up (> 1 year) of Plasma Donors and Patients treated with COVID-19 Convalescent Plasma within the CAPSID trial
19. COVID-19, 9. Hämotherapie
22.09.2022
14:00 – 14:10 6 Min. 4 Min.
Abstractvortrag
VS-13-4
A Randomised Open-Label Trial of Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19 as model of early treatment in a pandemia with a new pathogen: Experience from collection of very high-titer plasma from superimmunized individuals
1. Blutspende und Donormanagement, 19. COVID-19
22.09.2022
16:40 – 16:45 3 Min. 2 Min.
Poster
PS-1-4
Establishment of a mobile plasma donation bus in Germany
1. Blutspende und Donormanagement, 2. Versorgungsforschung